These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9817626)

  • 1. Saliva level of free 3-methoxy-4-hydroxyphenylglycol in psychiatric outpatients with anxiety.
    Yamada S; Yajima J; Harano M; Miki K; Nakamura J; Tsuda A; Shoji H; Maeda H; Tanaka M
    Int Clin Psychopharmacol; 1998 Sep; 13(5):213-7. PubMed ID: 9817626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Saliva level of free-3-methoxy-4-hydroxyphenylglycol in patients with anxiety disorders].
    Yamada S; Yajima J; Tsuda A; Yamauchi K; Maeda H; Tanaka M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Apr; 19(2):67-71. PubMed ID: 10464777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saliva level of free 3-methoxy-4-hydroxyphenylglycol (MHPG) as a biological index of anxiety disorders.
    Yamada S; Yamauchi K; Yajima J; Hisadomi S; Maeda H; Toyomasu K; Tanaka M
    Psychiatry Res; 2000 Apr; 93(3):217-23. PubMed ID: 10760380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of mental condition by saliva level of 3-methoxy-4-hydroxyphenylglycol].
    Yamada S
    Seishin Shinkeigaku Zasshi; 2005; 107(7):712-7. PubMed ID: 16146187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of short-term anxiolytic potency of alprazolam and tandospirone in psychiatric outpatients with anxiety disorders.
    Yamauchi K; Yamada S; Morita K; Maeda H; Tanaka M
    Hum Psychopharmacol; 2001 Aug; 16(6):469-473. PubMed ID: 12404555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in saliva and plasma of healthy volunteers.
    Yang RK; Yehuda R; Holland DD; Knott PJ
    Biol Psychiatry; 1997 Nov; 42(9):821-6. PubMed ID: 9347131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment urinary MHPG levels as predictors of antidepressant responses to alprazolam.
    Mooney JJ; Cole JO; Schatzberg AF; Gerson B; Schildkraut JJ
    Am J Psychiatry; 1985 Mar; 142(3):366-7. PubMed ID: 2857533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.
    Charney DS; Heninger GR
    Arch Gen Psychiatry; 1985 May; 42(5):458-67. PubMed ID: 2859008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low MHPG and continuing treatment in panic disorder.
    Edlund MJ; Swann AC
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(5):701-7. PubMed ID: 2781042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled clinical trial of alprazolam for the treatment of anxiety.
    Rickels K; Csanalosi I; Greisman P; Cohen D; Werblowsky J; Ross HA; Harris H
    Am J Psychiatry; 1983 Jan; 140(1):82-5. PubMed ID: 6128927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants.
    Mooney JJ; Schatzberg AF; Cole JO; Samson JA; Waternaux C; Gerson B; Pappalardo KM; Schildkraut JJ
    J Clin Psychopharmacol; 1991 Dec; 11(6):339-43. PubMed ID: 1770151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a relationship between MHPG and anxiety in depressed patients?
    Garvey M; Hollon S; DeRubeis R
    Psychiatry Res; 1991 Aug; 38(2):187-95. PubMed ID: 1754631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of effect of anxiety on total plasma MHPG in depressed patients.
    Karege F; Bovier P; Hilleret H; Gaillard JM
    J Affect Disord; 1993 Jul; 28(3):211-7. PubMed ID: 8408983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of panic disorder and its treatment outcome to 24-hour urinary MHPG levels.
    Garvey M; Noyes R; Cook B; Tollefson G
    Psychiatry Res; 1989 Oct; 30(1):53-61. PubMed ID: 2594871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alprazolam in the treatment of neurotic anxiety.
    Kerry RJ; McDermott CM
    Pharmatherapeutica; 1983; 3(7):451-5. PubMed ID: 6142462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal profile of brain response to alprazolam in patients with generalized anxiety disorder.
    Brown GG; Ostrowitzki S; Stein MB; von Kienlin M; Liu TT; Simmons A; Wierenga C; Stein OY; Bruns A; Bischoff-Grethe A; Paulus M
    Psychiatry Res; 2015 Sep; 233(3):394-401. PubMed ID: 26211623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder.
    Enkelmann R
    Psychopharmacology (Berl); 1991; 105(3):428-32. PubMed ID: 1798836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of alprazolam on the symptoms of anxiety and depression].
    Małyszczak K; Kiejna A
    Psychiatr Pol; 1997; 31(6):745-52. PubMed ID: 9515306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.